BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 24550282)

  • 21. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells.
    Gan B; Hu J; Jiang S; Liu Y; Sahin E; Zhuang L; Fletcher-Sananikone E; Colla S; Wang YA; Chin L; Depinho RA
    Nature; 2010 Dec; 468(7324):701-4. PubMed ID: 21124456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
    Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X
    Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of hypoxia-inducible factor-1α, regulated in development and DNA damage response-1 and mammalian target of rapamycin in human placental BeWo cells under hypoxia.
    Zhou F; Guan LB; Yu P; Wang XD; Hu YY
    Placenta; 2016 Sep; 45():24-31. PubMed ID: 27577706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
    Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
    Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
    Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
    J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells.
    Sudhagar S; Sathya S; Lakshmi BS
    Br J Cancer; 2011 Sep; 105(7):953-60. PubMed ID: 21897387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
    Shukuya T; Yamada T; Koenig MJ; Xu J; Okimoto T; Li F; Amann JM; Carbone DP
    J Thorac Oncol; 2019 Jun; 14(6):1061-1076. PubMed ID: 30825612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
    Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
    BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.
    Faubert B; Vincent EE; Poffenberger MC; Jones RG
    Cancer Lett; 2015 Jan; 356(2 Pt A):165-70. PubMed ID: 24486219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism.
    Izreig S; Samborska B; Johnson RM; Sergushichev A; Ma EH; Lussier C; Loginicheva E; Donayo AO; Poffenberger MC; Sagan SM; Vincent EE; Artyomov MN; Duchaine TF; Jones RG
    Cell Rep; 2016 Aug; 16(7):1915-28. PubMed ID: 27498867
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
    Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
    [No Abstract]   [Full Text] [Related]  

  • 35. Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways.
    Andrade-Vieira R; Xu Z; Colp P; Marignani PA
    PLoS One; 2013; 8(2):e56567. PubMed ID: 23451056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mTOR activates hypoxia-inducible factor-1α and inhibits neuronal apoptosis in the developing rat brain during the early phase after hypoxia-ischemia.
    Chen H; Xiong T; Qu Y; Zhao F; Ferriero D; Mu D
    Neurosci Lett; 2012 Jan; 507(2):118-23. PubMed ID: 22178140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.
    Cam H; Easton JB; High A; Houghton PJ
    Mol Cell; 2010 Nov; 40(4):509-20. PubMed ID: 21095582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.
    Wolff NC; Vega-Rubin-de-Celis S; Xie XJ; Castrillon DH; Kabbani W; Brugarolas J
    Mol Cell Biol; 2011 May; 31(9):1870-84. PubMed ID: 21383064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation.
    Lai LP; Lilley BN; Sanes JR; McMahon AP
    Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19450-5. PubMed ID: 24218567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-O-methylascochlorin, methylated derivative of ascochlorin, stabilizes HIF-1α via AMPK activation.
    Jeong JH; Kang JH; Hwang SL; Cho HJ; Park KK; Park YY; Chung IK; Chang HW; Kim CH; Min KS; Kim HD; Magae J; Kang SS; Chang YC
    Biochem Biophys Res Commun; 2011 Mar; 406(3):353-8. PubMed ID: 21329651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.